Beijing Leadman Biochemistry (300289.SZ): fsg medical serv a AI transformation is currently one of the industry development trends closely monitored by the company.

Gelonghui November 8th | Beijing Leadman Biochemistry (300289.SZ) stated on the investor interactive platform that medical AI is currently one of the closely watched industry development trends by the company.

Gelonghui FinanceNov 8 16:04

Beijing Leadman Biochemistry (300289.SZ): The patented application scenarios of microfluidic fluorescence immunoassay chip technology are in the field of clinical immunological analysis.

Gelonghui November 1st | Beijing Leadman Biochemistry (300289.SZ) stated on the investor interaction platform that the patented application scenarios of the microfluidic fluorescence immunoassay chip technology obtained by the company are in the field of immunological analysis in clinical testing.

Gelonghui FinanceNov 1 20:58

Express News | Beijing Leadman Biochemistry reached a strategic cooperation agreement with Russia's VT Company to jointly expand the layout construction of overseas markets.

BreakingsOct 30 11:30

Leadman: Third quarter report 2024

SZSIOct 26 00:00 · Announcements

Beijing Leadman Biochemistry (300289.SZ): The net income in the first three quarters was 1.0716 million yuan, a year-on-year decrease of 95.49%.

Glonghui, October 25 | Leadman (300289.SZ) released its third quarter report. In the first three quarters of 2024, the company achieved operating income of 0.282 billion yuan, a year-on-year decrease of 17.15%; net profit attributable to shareholders of listed companies was 1.0716 million yuan, a year-on-year decrease of 95.49%; net loss after deducting non-recurring profit and loss was 6.5087 million yuan, a year-on-year decrease of 130.05%; basic earnings per share were 0.0020 yuan/share.

Gelonghui FinanceOct 25 16:36

Beijing Leadman Biochemistry (300289.SZ) released its performance for the first three quarters, with a net income of 1.0716 million yuan, a year-on-year decrease of 95.49%.

Beijing Leadman Biochemistry (300289.SZ) released the third quarter report for 2024, with revenue in the first three quarters at 2.8...

Zhitong FinanceOct 25 16:28